CEL SCI CORP
10-K, EX-27, 2000-12-27
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: CEL SCI CORP, 10-K, EX-23, 2000-12-27
Next: NYLIAC MFA SEPARATE ACCOUNT I, 497, 2000-12-27



<TABLE> <S> <C>


<ARTICLE>                     5

<CIK>                                          0000725363
<NAME>                                         Cel-Sci Corporation
<MULTIPLIER>                                   1
<CURRENCY>                                     US

<S>                             <C>
<PERIOD-TYPE>                                  12-MOS
<FISCAL-YEAR-END>                              SEP-30-2000
<PERIOD-START>                                 OCT-1-1999
<PERIOD-END>                                   SEP-30-2000
<EXCHANGE-RATE>                                1
<CASH>                                         6,909,263
<SECURITIES>                                   3,760,922
<RECEIVABLES>                                  39,980
<ALLOWANCES>                                   0
<INVENTORY>                                    0
<CURRENT-ASSETS>                               12,548,541
<PP&E>                                         2,316,255
<DEPRECIATION>                                 1,721,336
<TOTAL-ASSETS>                                 13,808,882
<CURRENT-LIABILITIES>                          822,601
<BONDS>                                        0
                          0
                                    0
<COMMON>                                       204,597
<OTHER-SE>                                     12,756,862
<TOTAL-LIABILITY-AND-EQUITY>                   13,808,882
<SALES>                                        0
<TOTAL-REVENUES>                               442,551
<CGS>                                          0
<TOTAL-COSTS>                                  8,920,948
<OTHER-EXPENSES>                               0
<LOSS-PROVISION>                               0
<INTEREST-EXPENSE>                             0
<INCOME-PRETAX>                                (8,478,397)
<INCOME-TAX>                                   0
<INCOME-CONTINUING>                            (8,478,397)
<DISCONTINUED>                                 0
<EXTRAORDINARY>                                0
<CHANGES>                                      0
<NET-INCOME>                                   (8,478,397)
<EPS-BASIC>                                    (0.44)
<EPS-DILUTED>                                  (0.44)



</TABLE>


© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission